Literature DB >> 16009556

The spliceosome: a novel multi-faceted target for therapy.

Jamal Tazi1, Sébastien Durand, Philippe Jeanteur.   

Abstract

The spliceosome is a dynamic and flexible ribonucleoprotein enzyme that removes intronic sequences in a regulated manner. Spliceosome action enables one stretch of genomic DNA sequence to yield several mRNAs that encode different proteins. It depends on a flexible mechanism for selecting splice sites, which calls for regulatory sequences (splicing enhancers or silencers) recognized by cognate trans-acting protein factors and constitutive ribonucleoprotein devices to build up the catalytic core. The identification of both types of elements now offers a comprehensive insight into how the spliceosome is adapted to carry out the removal of different introns and suggests novel therapeutic targets to, ultimately, restore a physiological pattern of alternatively spliced variants in a large repertoire of pathologies.

Mesh:

Substances:

Year:  2005        PMID: 16009556     DOI: 10.1016/j.tibs.2005.06.002

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  25 in total

1.  G2E3 is a nucleo-cytoplasmic shuttling protein with DNA damage responsive localization.

Authors:  William S Brooks; Sami Banerjee; David F Crawford
Journal:  Exp Cell Res       Date:  2006-12-14       Impact factor: 3.905

2.  Alternative splicing as a therapeutic target for human diseases.

Authors:  Kenneth J Dery; Veronica Gusti; Shikha Gaur; John E Shively; Yun Yen; Rajesh K Gaur
Journal:  Methods Mol Biol       Date:  2009

3.  Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing.

Authors:  Jonathan L Chen; Peiyuan Zhang; Masahito Abe; Haruo Aikawa; Liying Zhang; Alexander J Frank; Timothy Zembryski; Christopher Hubbs; HaJeung Park; Jane Withka; Claire Steppan; Lucy Rogers; Shawn Cabral; Martin Pettersson; Travis T Wager; Matthew A Fountain; Gavin Rumbaugh; Jessica L Childs-Disney; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2020-05-04       Impact factor: 15.419

Review 4.  Mechanisms and Regulation of Alternative Pre-mRNA Splicing.

Authors:  Yeon Lee; Donald C Rio
Journal:  Annu Rev Biochem       Date:  2015-03-12       Impact factor: 23.643

5.  Conditional control of alternative splicing through light-triggered splice-switching oligonucleotides.

Authors:  James Hemphill; Qingyang Liu; Rajendra Uprety; Subhas Samanta; Michael Tsang; Rudolph L Juliano; Alexander Deiters
Journal:  J Am Chem Soc       Date:  2015-03-03       Impact factor: 15.419

6.  Thiamine biosynthesis in algae is regulated by riboswitches.

Authors:  Martin T Croft; Michael Moulin; Michael E Webb; Alison G Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

7.  Proximity-dependent and proximity-independent trans-splicing in mammalian cells.

Authors:  Kristi D Viles; Bruce A Sullenger
Journal:  RNA       Date:  2008-04-25       Impact factor: 4.942

8.  Propionic and methylmalonic acidemia: antisense therapeutics for intronic variations causing aberrantly spliced messenger RNA.

Authors:  A Rincón; C Aguado; L R Desviat; R Sánchez-Alcudia; M Ugarte; B Pérez
Journal:  Am J Hum Genet       Date:  2007-12       Impact factor: 11.025

9.  Molecular architecture of zinc chelating small molecules that inhibit spliceosome assembly at an early stage.

Authors:  Vishal Patil; Josh C Canzoneri; Timur R Samatov; Reinhard Lührmann; Adegboyega K Oyelere
Journal:  RNA       Date:  2012-07-25       Impact factor: 4.942

10.  Slc11a1 (formerly Nramp1) and susceptibility to canine visceral leishmaniasis.

Authors:  Elisenda Sanchez-Robert; Laura Altet; Mireia Utzet-Sadurni; Urs Giger; Armand Sanchez; Olga Francino
Journal:  Vet Res       Date:  2008-02-29       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.